Sébastien Imbert

Dr. Sébastien Imbert

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
SISébastien Imbert
Sébastien Imbert
LGL. Gauthier
L. Gauthier
IJI. Joly
I. Joly
JBJ.-Y. Brossas
J.-Y. Brossas
MUM. Uzunov
M. Uzunov
AFArnaud Fekkar
Arnaud Fekkar

19 October 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
ANAnne-Cécile Normand
Anne-Cécile Normand
AMAlicia Moreno-Sabater
Alicia Moreno-Sabater
AJArnaud Jabet
Arnaud Jabet
SHSamia Hamane
Samia Hamane
GCGeneviève Cremer
Geneviève Cremer
RPrenaud piarroux
renaud piarroux
Trichophyton indotineae is an emerging pathogen which recently spread from India to Europe and that is more prone than other species of the Trichophyton mentagrophytes complex to show resistance to terbinafine, resulting in the necessity of rapid identification. Here, we improved the online MSI-2 MALDI-TOF identification tool in order to identify T. indotineae. By multiplying the culture conditions (2 culture media and 6 stages of growth) prior to protein extractions for both test isolates and reference strains, we added 142 references corresponding to 12 strains inside the T. mentagrophytes complex in the online MSI-2 database, of which 3 are T. indotineae strains. The resulting database was tested with 1566 spectra of 67 isolates from the T. mentagrophytes complex, including 16 T. indotineae isolates. Using the newly improved MSI-2 database, we increased the identification rate of T. indotineae from 5% to 96%, with a sensitivity of 99.6%. We also identified specific peaks (6834/6845 daltons and 10,634/10,680 daltons) allowing for the distinction of T. indotineae from the other species of the complex. Our improved version of the MSI-2 application allows for the identification of T. indotineae. This will improve the epidemiological knowledge of the spread of this species throughout the world and will help to improve patient care.

9 April 2014 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
AFA. Fekkar
A. Fekkar
Eric DannaouiEric Dannaoui
Eric Dannaoui
IMI. Meyer
I. Meyer
SISébastien Imbert
Sébastien Imbert
JBJ. Y. Brossas
J. Y. Brossas
ADA. Datry
A. Datry

25 January 2019 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
SISébastien Imbert
Sébastien Imbert
ANAnne-Cécile Normand
Anne-Cécile Normand
FGFrédéric Gabriel
Frédéric Gabriel
SCSophie Cassaing
Sophie Cassaing
CBChristine BONNAL
Christine BONNAL
AFArnaud Fekkar
Arnaud Fekkar
The taxonomy of Aspergillus species has recently been revolutionized with the introduction of cryptic species and section concepts. However, their species-level identification in routine laboratories remains a challenge. The aim of this study was to prospectively assess the identification accuracy of cryptic species of Aspergillus in various laboratories using the mass spectrometry identification (MSI) platform, an independent and freely accessible online mass spectrometry database. Over a 12-month period, when a select set of MSI users identified cryptic species, they were contacted and requested to send the isolates to our laboratory for sequence-based identification. Sequence and MSI identification results were then compared. During the study period, 5108 Aspergillus isolates were identified using MSI including 1477 (28.9%) cryptic species. A total of 245 isolates that corresponded to 56 cryptic species and 13 sections were randomly selected for DNA sequencing confirmation. Agreement between the two methods was 99.6% at the section level and 66.1% at the species level. However, almost all discrepancies (72/83, 86.7%) were misidentifications between closely related cryptic species belonging to the same section. Fifty-one isolates from noncryptic species were also identified, thus yielding 100% and 92.2% agreement at the section and species level, respectively. Although the MSI fungus database is a reliable tool to identify Aspergillus at the section level, the database still requires adjustment to correctly identify rare or cryptic species at the species level. Nevertheless, the application properly differentiated between cryptic and sensu stricto species in the same section, thus alerting on possible specific isolate characteristics.

14 August 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
SISébastien Imbert
Sébastien Imbert
IMIsabelle Meyer
Isabelle Meyer
MPMartine Palous
Martine Palous
JBJean-Yves Brossas
Jean-Yves Brossas
MUMadalina Uzunov
Madalina Uzunov
AFArnaud Fekkar
Arnaud Fekkar
Objectives: We evaluated the usefulness of an Aspergillus fumigatus quantitative PCR assay performed in bronchoalveolar lavage fluid (BAL) for the diagnosis and prognosis of both invasive and non-invasive aspergillosis. Methods: This 4-year retrospective study involved 613 at-risk patients who had either hematological disorders or other immunosuppressive conditions, notably solid organ transplants. Thirty-five patients had proven/probable aspergillosis and thirteen had chronic non-invasive aspergillosis. We compared PCR, galactomannan index and mycological analysis of BAL. Results: For invasive aspergillosis (IA), PCR performed in BAL yielded 88.6% sensitivity and 95.5% specificity. Comparatively, galactomannan index and mycological examination yielded only 56.3 and 63.6% sensitivity and 97.6 and 94.5% specificity, respectively. Considering the 13 chronic aspergillosis cases, PCR, galactomannan index and mycological examination yielded 76.9, 15.4, and 84.6% sensitivity and 92.2, 94.9, and 93% specificity, respectively. Fungal load in BAL evaluated by PCR was able to discriminate between aspergillosis and contamination, but not between invasive and non-invasive forms. Finally, fungal load was predictive of 90-day mortality, with 23.1% mortality for patients with less than 500 copies/mL versus 68.4% for patients above that cut-off (p < 0.05). Conclusion: Our results indicate that Aspergillus PCR in BAL is of particular interest for both the diagnosis and the prognosis of IA. It is likewise an interesting tool for the diagnosis of non-invasive forms.

26 January 2023 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
SISébastien Imbert
Sébastien Imbert
LPL Portejoie
L Portejoie
EPE Pfister
E Pfister
BTB Tauzin
B Tauzin
MRM Revers
M Revers
LDL Delhaes
L Delhaes
There has been significant increase in the use of molecular tools for the diagnosis of invasive aspergillosis (IA) and mucormycosis. However, their range of detection may be too limited as species diversity and coinfections are increasing.